Perspective Therapeutics (CATX) Earnings Date & Reports
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more
CATX is expected to report earnings to fall 5.43% to -33 cents per share on March 26
Q4'25
Est.
$-0.33
Q3'25
Missed
by $0.03
Q2'25
Est.
$-0.29
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.30
The last earnings report on November 10 showed earnings per share of -34 cents, missing the estimate of -31 cents. With 1.72M shares outstanding, the current market capitalization sits at 157.60M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CATX showed earnings on November 10, 2025. You can read more about the earnings report here.